A longitudinal cohort study in a tertiary Italian hospital investigating HIV+ patients starting a triple therapy or dual therapy regimen
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Darunavir (Primary) ; Dolutegravir/rilpivirine (Primary) ; Emtricitabine (Primary) ; Lamivudine (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 03 Sep 2021 New trial record